Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Post-traumatic stress disorder drug risperidone not working: Study

According to a new study a medication commonly used to treat post-traumatic stress disorder in combat veterans may not be effective in reducing overall PTSD severity.

3 Aug 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

Surge of generics will trigger drop in drug prices

In the next 14 months, seven of the world's 20 best-selling drugs are scheduled to go "off patent." As they do, the brand-name drugs will lose out to generic versions, cutting costs for patients and companies that provide health benefits.

27 Jul 2011

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Neuralstem, Inc. announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth."

15 Jul 2011

HIV patients with mental illness can benefit from APRN care management

In a four-year study, researchers at the University of Pennsylvania have found that assigning adults with serious mental health illness who are HIV positive to the care of advanced practice nurses (APRN) to help navigate the health care system and maintain adherence to drug regimens reduced depression and improved their overall physical health, indicating that healthcare policy should be revamped to provide this support.

12 Jul 2011

Study may help explain why antipsychotic drugs can promote overeating, weight gain

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic drugs can promote overeating, weight gain, and insulin resistance.

12 Jul 2011

Lithium can prevent aggregation of toxic proteins and cell loss linked with Parkinson's

Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.

24 Jun 2011

Longer looks: Prenatal care for dads; rise in bipolar diagnosis for children

Perhaps it's because mom has the burgeoning belly, but dads have largely been left out of prenatal care. That could be damaging to the family's health, contends research in a recent issue of the Journal of Advanced Nursing.

24 Jun 2011

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.

22 Jun 2011

Risperidone recall by J&J

Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.

19 Jun 2011

SPI and Neuralstem sign licensing agreement for major depression drug, NSI-189

Neuralstem, Inc. announced that it has signed an exclusive agency licensing agreement with Summit Pharmaceuticals International Corporation, of Tokyo, Japan (SPI), a wholly owned subsidiary of Sumitomo Corporation Group.

8 Jun 2011

Brain areas responsible for motor behavior might represent therapeutic targets for bipolar disorder

A new study by motor control and psychology researchers at Indiana University suggests that postural control problems may be a core feature of bipolar disorder, not just a random symptom, and can provide insights both into areas of the brain affected by the psychiatric disorder and new potential targets for treatment.

25 May 2011

New clinical research study to compare two medications for bipolar disorder

Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications -- quetiapine, a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.

25 May 2011

Disaster-response planning raises challenges for mental health services, bioethicists say

Johns Hopkins University bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions.

24 May 2011

Johns Hopkins bioethicists urge disaster preparedness for mentally impaired

Johns Hopkins bioethicists say disaster-response planning has generally overlooked the special needs of people who suffer from pre-existing and serious mental conditions. Survivors already diagnosed with schizophrenia, dementia, addictions and bipolar disorder are vulnerable long before a disaster strikes, they point out.

23 May 2011

Cognitive behavioral group therapy may help prevent new episodes of bipolar disorder

In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.

23 May 2011

Naurex announces completion of $18 million Series A financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.

11 May 2011

Psychotherapeutic treatment can cure cyclothymic disorder

In the current issue of Psychotherapy and Psychosomatics a group of Italian investigators headed by Giovanni Fava published a randomized controlled trial on psychotherapeutic treatment of cyclothymic disorder, a disturbance that is characterized by rapid alternation of mood swings.

9 May 2011

Summit Entertainment, Participant Media create depression awareness campaign

Inspired by Participant Media and Summit Entertainment's THE BEAVER, Participant has created a Social public Action Campaign to increase awareness about depression, teaming with three leading non-profit organizations known for effectively providing hope and help to those affected by depression and other forms of mental illness: the National Alliance on Mental Illness, To Write Love on Her Arms (TWLOHA) and the Kristin Brooks Hope Center.

7 May 2011

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

The House is slated Thursday to take up a conference committee report on a bill designed to put the state on the path to universal health care by 2017 if not sooner. The bill sets up a new Green Mountain Care Board to design a system to provide health insurance to every Vermont resident.

6 May 2011